{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:27:43Z","timestamp":1776486463764,"version":"3.51.2"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:00:00Z","timestamp":1474502400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12035-016-0116-8","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T04:48:49Z","timestamp":1474519729000},"page":"5709-5719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Serum Markers of Neurodegeneration in Maple Syrup Urine Disease"],"prefix":"10.1007","volume":"54","author":[{"given":"Giselli","family":"Scaini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e1ssia","family":"Tonon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina F. Moura","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia F.","family":"Schuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao Seda","family":"Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Amorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida Vanessa D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio L.","family":"Streck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,22]]},"reference":[{"key":"116_CR1","first-page":"1971","volume-title":"The metabolic and molecular bases of inherited disease","author":"DT Chuang","year":"2001","unstructured":"Chuang DT, Shih VE (2001) Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp. 1971\u20132005"},{"issue":"1","key":"116_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","volume":"82","author":"S Schonberger","year":"2004","unstructured":"Schonberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82(1):69\u201375. doi: 10.1016\/j.ymgme.2004.01.016","journal-title":"Mol Genet Metab"},{"key":"116_CR3","first-page":"3","volume":"55","author":"SE Snyderman","year":"1964","unstructured":"Snyderman SE, LE H Jr (1964) Maple syrup urine disease. J Maine Med Assoc 55:3\u20135","journal-title":"J Maine Med Assoc"},{"issue":"2","key":"116_CR4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0887-8994(92)90038-Z","volume":"8","author":"A Kamei","year":"1992","unstructured":"Kamei A, Takashima S, Chan F, Becker LE (1992) Abnormal dendritic development in maple syrup urine disease. Pediatr Neurol 8(2):145\u2013147","journal-title":"Pediatr Neurol"},{"issue":"6","key":"116_CR5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-0186(00)00100-5","volume":"38","author":"P Araujo","year":"2001","unstructured":"Araujo P, Wassermann GF, Tallini K, Furlanetto V, Vargas CR, Wannmacher CM, Dutra-Filho CS, Wyse AT, Wajner M (2001) Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int 38(6):529\u2013537","journal-title":"Neurochem Int"},{"issue":"5","key":"116_CR6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1005668431926","volume":"23","author":"M Wajner","year":"2000","unstructured":"Wajner M, Coelho DM, Barschak AG, Araujo PR, Pires RF, Lulhier FL, Vargas CR (2000) Reduction of large neutral amino acid concentrations in plasma and CSF of patients with maple syrup urine disease during crises. J Inherit Metab Dis 23(5):505\u2013512","journal-title":"J Inherit Metab Dis"},{"issue":"Pt 4","key":"116_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/brain\/awp024","volume":"132","author":"WJ Zinnanti","year":"2009","unstructured":"Zinnanti WJ, Lazovic J, Griffin K, Skvorak KJ, Paul HS, Homanics GE, Bewley MC, Cheng KC, Lanoue KF, Flanagan JM (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132(Pt 4):903\u2013918. doi: 10.1093\/brain\/awp024","journal-title":"Brain"},{"key":"116_CR8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-113-28456","volume":"113","author":"RK Howell","year":"1963","unstructured":"Howell RK, Lee M (1963) Influence of alpha-ketoacids on the respiration of brain in vitro. Proc Soc Exp Biol Med 113:660\u2013663","journal-title":"Proc Soc Exp Biol Med"},{"issue":"3","key":"116_CR9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2003.09.010","volume":"1639","author":"AM Sgaravatti","year":"2003","unstructured":"Sgaravatti AM, Rosa RB, Schuck PF, Ribeiro CA, Wannmacher CM, Wyse AT, Dutra-Filho CS, Wajner M (2003) Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639(3):232\u2013238","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"116_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11064-007-9423-9","volume":"33","author":"CA Ribeiro","year":"2008","unstructured":"Ribeiro CA, Sgaravatti AM, Rosa RB, Schuck PF, Grando V, Schmidt AL, Ferreira GC, Perry ML, Dutra-Filho CS, Wajner M (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33(1):114\u2013124. doi: 10.1007\/s11064-007-9423-9","journal-title":"Neurochem Res"},{"key":"116_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainres.2010.02.018","volume":"1324","author":"AU Amaral","year":"2010","unstructured":"Amaral AU, Leipnitz G, Fernandes CG, Seminotti B, Schuck PF, Wajner M (2010) Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain. Brain Res 1324:75\u201384. doi: 10.1016\/j.brainres.2010.02.018","journal-title":"Brain Res"},{"key":"116_CR12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1749-6632.2000.tb05604.x","volume":"926","author":"P Jouvet","year":"2000","unstructured":"Jouvet P, Kozma M, Mehmet H (2000) Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids. Ann N Y Acad Sci 926:116\u2013121","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"116_CR13","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1091\/mbc.11.5.1919","volume":"11","author":"P Jouvet","year":"2000","unstructured":"Jouvet P, Rustin P, Taylor DL, Pocock JM, Felderhoff-Mueser U, Mazarakis ND, Sarraf C, Joashi U, Kozma M, Greenwood K, Edwards AD, Mehmet H (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11(5):1919\u20131932","journal-title":"Mol Biol Cell"},{"issue":"1","key":"116_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1014004414733","volume":"17","author":"FU Fontella","year":"2002","unstructured":"Fontella FU, Gassen E, Pulrolnik V, Wannmacher CM, Klein AB, Wajner M, Dutra-Filho CS (2002) Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17(1):47\u201354","journal-title":"Metab Brain Dis"},{"issue":"6","key":"116_CR15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0736-5748(03)00074-1","volume":"21","author":"R Bridi","year":"2003","unstructured":"Bridi R, Araldi J, Sgarbi MB, Testa CG, Durigon K, Wajner M, Dutra-Filho CS (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci Off J Int Soc Dev Neurosci 21(6):327\u2013332","journal-title":"Int J Dev Neurosci Off J Int Soc Dev Neurosci"},{"issue":"2","key":"116_CR16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11011-005-4152-8","volume":"20","author":"R Bridi","year":"2005","unstructured":"Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS (2005) Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab Brain Dis 20(2):155\u2013167","journal-title":"Metab Brain Dis"},{"issue":"1","key":"116_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11011-007-9077-y","volume":"23","author":"AG Barschak","year":"2008","unstructured":"Barschak AG, Sitta A, Deon M, Barden AT, Dutra-Filho CS, Wajner M, Vargas CR (2008) Oxidative stress in plasma from maple syrup urine disease patients during treatment. Metab Brain Dis 23(1):71\u201380. doi: 10.1007\/s11011-007-9077-y","journal-title":"Metab Brain Dis"},{"issue":"6","key":"116_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.clinbiochem.2008.12.005","volume":"42","author":"AG Barschak","year":"2009","unstructured":"Barschak AG, Sitta A, Deon M, Busanello EN, Coelho DM, Cipriani F, Dutra-Filho CS, Giugliani R, Wajner M, Vargas CR (2009) Amino acids levels and lipid peroxidation in maple syrup urine disease patients. Clin Biochem 42(6):462\u2013466. doi: 10.1016\/j.clinbiochem.2008.12.005","journal-title":"Clin Biochem"},{"key":"116_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mrfmmm.2015.03.008","volume":"775","author":"CP Mescka","year":"2015","unstructured":"Mescka CP, Guerreiro G, Hammerschmidt T, Faverzani J, de Moura Coelho D, Mandredini V, Wayhs CA, Wajner M, Dutra-Filho CS, Vargas CR (2015) L-Carnitine supplementation decreases DNA damage in treated MSUD patients. Mutat Res 775:43\u201347. doi: 10.1016\/j.mrfmmm.2015.03.008","journal-title":"Mutat Res"},{"issue":"1","key":"116_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijdevneu.2012.10.109","volume":"31","author":"CP Mescka","year":"2013","unstructured":"Mescka CP, Wayhs CA, Vanzin CS, Biancini GB, Guerreiro G, Manfredini V, Souza C, Wajner M, Dutra-Filho CS, Vargas CR (2013) Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 31(1):21\u201324. doi: 10.1016\/j.ijdevneu.2012.10.109","journal-title":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience"},{"issue":"2","key":"116_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ymgme.2012.04.009","volume":"106","author":"G Scaini","year":"2012","unstructured":"Scaini G, Jeremias IC, Morais MO, Borges GD, Munhoz BP, Leffa DD, Andrade VM, Schuck PF, Ferreira GC, Streck EL (2012) DNA damage in an animal model of maple syrup urine disease. Mol Genet Metab 106(2):169\u2013174. doi: 10.1016\/j.ymgme.2012.04.009","journal-title":"Mol Genet Metab"},{"issue":"5","key":"116_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10545-012-9549-z","volume":"36","author":"G Scaini","year":"2013","unstructured":"Scaini G, Comim CM, Oliveira GM, Pasquali MA, Quevedo J, Gelain DP, Moreira JC, Schuck PF, Ferreira GC, Bogo MR, Streck EL (2013) Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model. J Inherit Metab Dis 36(5):721\u2013730. doi: 10.1007\/s10545-012-9549-z","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"116_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s12035-013-8447-1","volume":"48","author":"G Scaini","year":"2013","unstructured":"Scaini G, Mello-Santos LM, Furlanetto CB, Jeremias IC, Mina F, Schuck PF, Ferreira GC, Kist LW, Pereira TC, Bogo MR, Streck EL (2013) Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus. Mol Neurobiol 48(3):581\u2013589. doi: 10.1007\/s12035-013-8447-1","journal-title":"Mol Neurobiol"},{"issue":"5","key":"116_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11064-015-1541-1","volume":"40","author":"G Scaini","year":"2015","unstructured":"Scaini G, Morais MO, Furlanetto CB, Kist LW, Pereira TC, Schuck PF, Ferreira GC, Pasquali MA, Gelain DP, Moreira JC, Bogo MR, Streck EL (2015) Acute administration of branched-chain amino acids increases the pro-BDNF\/Total-BDNF ratio in the rat brain. Neurochem Res 40(5):885\u2013893. doi: 10.1007\/s11064-015-1541-1","journal-title":"Neurochem Res"},{"issue":"2","key":"116_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12035-012-8243-3","volume":"45","author":"G Scaini","year":"2012","unstructured":"Scaini G, de Rochi N, Jeremias IC, Deroza PF, Zugno AI, Pereira TC, Oliveira GM, Kist LW, Bogo MR, Schuck PF, Ferreira GC, Streck EL (2012) Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease. Mol Neurobiol 45(2):279\u2013286. doi: 10.1007\/s12035-012-8243-3","journal-title":"Mol Neurobiol"},{"issue":"5","key":"116_CR26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/187152711796235032","volume":"10","author":"S Capsoni","year":"2011","unstructured":"Capsoni S, Brandi R, Arisi I, D\u2019Onofrio M, Cattaneo A (2011) A dual mechanism linking NGF\/proNGF imbalance and early inflammation to Alzheimer\u2019s disease neurodegeneration in the AD11 anti-NGF mouse model. CNS & neurological disorders drug targets 10(5):635\u2013647","journal-title":"CNS & neurological disorders drug targets"},{"issue":"4\u20136","key":"116_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10571-006-9112-2","volume":"26","author":"S Capsoni","year":"2006","unstructured":"Capsoni S, Cattaneo A (2006) On the molecular basis linking nerve growth factor (NGF) to Alzheimer\u2019s disease. Cell Mol Neurobiol 26(4\u20136):619\u2013633. doi: 10.1007\/s10571-006-9112-2","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"116_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s11064-007-9497-4","volume":"33","author":"A Contestabile","year":"2008","unstructured":"Contestabile A, Ciani E, Contestabile A (2008) The place of choline acetyltransferase activity measurement in the \u201ccholinergic hypothesis\u201d of neurodegenerative diseases. Neurochem Res 33(2):318\u2013327. doi: 10.1007\/s11064-007-9497-4","journal-title":"Neurochem Res"},{"issue":"2","key":"116_CR29","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1471-4159.1995.64020749.x","volume":"64","author":"LM Bierer","year":"1995","unstructured":"Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, Davis KL (1995) Neurochemical correlates of dementia severity in Alzheimer\u2019s disease: relative importance of the cholinergic deficits. J Neurochem 64(2):749\u2013760","journal-title":"J Neurochem"},{"issue":"9","key":"116_CR30","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/hbm.21111","volume":"32","author":"SJ Teipel","year":"2011","unstructured":"Teipel SJ, Meindl T, Grinberg L, Grothe M, Cantero JL, Reiser MF, Moller HJ, Heinsen H, Hampel H (2011) The cholinergic system in mild cognitive impairment and Alzheimer\u2019s disease: an in vivo MRI and DTI study. Hum Brain Mapp 32(9):1349\u20131362. doi: 10.1002\/hbm.21111","journal-title":"Hum Brain Mapp"},{"issue":"16","key":"116_CR31","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0047-6374(01)00309-8","volume":"122","author":"VN Talesa","year":"2001","unstructured":"Talesa VN (2001) Acetylcholinesterase in Alzheimer\u2019s disease. Mech Ageing Dev 122(16):1961\u20131969","journal-title":"Mech Ageing Dev"},{"key":"116_CR32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1749-6632.2002.tb04856.x","volume":"977","author":"S Mori","year":"2002","unstructured":"Mori S (2002) Responses to donepezil in Alzheimer\u2019s disease and Parkinson\u2019s disease. Ann N Y Acad Sci 977:493\u2013500","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"116_CR33","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1471-4159.1997.69031177.x","volume":"69","author":"G Sberna","year":"1997","unstructured":"Sberna G, Saez-Valero J, Beyreuther K, Masters CL, Small DH (1997) The amyloid beta-protein of Alzheimer\u2019s disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J Neurochem 69(3):1177\u20131184","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"116_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2005.09.063","volume":"1066","author":"AL Fu","year":"2005","unstructured":"Fu AL, Zhang XM, Sun MJ (2005) Antisense inhibition of acetylcholinesterase gene expression for treating cognition deficit in Alzheimer\u2019s disease model mice. Brain Res 1066(1\u20132):10\u201315. doi: 10.1016\/j.brainres.2005.09.063","journal-title":"Brain Res"},{"issue":"8","key":"116_CR35","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/NEN.0b013e3181aed9e6","volume":"68","author":"MA Bruno","year":"2009","unstructured":"Bruno MA, Leon WC, Fragoso G, Mushynski WE, Almazan G, Cuello AC (2009) Amyloid beta-induced nerve growth factor dysmetabolism in Alzheimer disease. J Neuropathol Exp Neurol 68(8):857\u2013869. doi: 10.1097\/NEN.0b013e3181aed9e6","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"116_CR36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/156720509787602870","volume":"6","author":"S Covaceuszach","year":"2009","unstructured":"Covaceuszach S, Capsoni S, Ugolini G, Spirito F, Vignone D, Cattaneo A (2009) Development of a non invasive NGF-based therapy for Alzheimer\u2019s disease. Current Alzheimer research 6(2):158\u2013170","journal-title":"Current Alzheimer research"},{"issue":"8","key":"116_CR37","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nn1510","volume":"8","author":"NH Woo","year":"2005","unstructured":"Woo NH, Teng HK, Siao CJ, Chiaruttini C, Pang PT, Milner TA, Hempstead BL, Lu B (2005) Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 8(8):1069\u20131077. doi: 10.1038\/nn1510","journal-title":"Nat Neurosci"},{"issue":"2","key":"116_CR38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0169-328X(00)00023-1","volume":"76","author":"RM Holsinger","year":"2000","unstructured":"Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M (2000) Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer\u2019s disease. Brain Res Mol Brain Res 76(2):347\u2013354","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"116_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.2000.7483","volume":"166","author":"DW Howells","year":"2000","unstructured":"Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, Donnan GA (2000) Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra. Exp Neurol 166(1):127\u2013135. doi: 10.1006\/exnr.2000.7483","journal-title":"Exp Neurol"},{"issue":"5529","key":"116_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293(5529):493\u2013498. doi: 10.1126\/science.1059581","journal-title":"Science"},{"issue":"1\u20132","key":"116_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jns.2011.12.014","volume":"315","author":"I Tasset","year":"2012","unstructured":"Tasset I, Sanchez-Lopez F, Aguera E, Fernandez-Bolanos R, Sanchez FM, Cruz-Guerrero A, Gascon-Luna F, Tunez I (2012) NGF and nitrosative stress in patients with Huntington\u2019s disease. J Neurol Sci 315(1\u20132):133\u2013136. doi: 10.1016\/j.jns.2011.12.014","journal-title":"J Neurol Sci"},{"key":"116_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/978-1-4419-1170-4_19","volume":"663","author":"LH Brennaman","year":"2010","unstructured":"Brennaman LH, Maness PF (2010) NCAM in neuropsychiatric and neurodegenerative disorders. Adv Exp Med Biol 663:299\u2013317. doi: 10.1007\/978-1-4419-1170-4_19","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"116_CR43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0006-3223(03)00182-3","volume":"54","author":"C Sandi","year":"2003","unstructured":"Sandi C, Merino JJ, Cordero MI, Kruyt ND, Murphy KJ, Regan CM (2003) Modulation of hippocampal NCAM polysialylation and spatial memory consolidation by fear conditioning. Biol Psychiatry 54(6):599\u2013607","journal-title":"Biol Psychiatry"},{"issue":"9","key":"116_CR44","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1111\/j.1460-9568.2006.04771.x","volume":"23","author":"L Stoenica","year":"2006","unstructured":"Stoenica L, Senkov O, Gerardy-Schahn R, Weinhold B, Schachner M, Dityatev A (2006) In vivo synaptic plasticity in the dentate gyrus of mice deficient in the neural cell adhesion molecule NCAM or its polysialic acid. Eur J Neurosci 23(9):2255\u20132264. doi: 10.1111\/j.1460-9568.2006.04771.x","journal-title":"Eur J Neurosci"},{"issue":"7","key":"116_CR45","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1523\/JNEUROSCI.3298-03.2004","volume":"24","author":"O Bukalo","year":"2004","unstructured":"Bukalo O, Fentrop N, Lee AY, Salmen B, Law JW, Wotjak CT, Schweizer M, Dityatev A, Schachner M (2004) Conditional ablation of the neural cell adhesion molecule reduces precision of spatial learning, long-term potentiation, and depression in the CA1 subfield of mouse hippocampus. The Journal of neuroscience : the official journal of the Society for Neuroscience 24(7):1565\u20131577. doi: 10.1523\/JNEUROSCI.3298-03.2004","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"116_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9313-0","author":"L Rosa","year":"2015","unstructured":"Rosa L, Galant LS, Dall\u2019Igna DM, Kolling J, Siebert C, Schuck PF, Ferreira GC, Wyse AT, Dal-Pizzol F, Scaini G, Streck EL (2015) Cerebral Oedema. Blood-brain barrier breakdown and the decrease in Na, K-ATPase activity in the cerebral cortex and hippocampus are prevented by dexamethasone in an animal model of maple syrup urine disease Molecular neurobiology. doi: 10.1007\/s12035-015-9313-0","journal-title":"Blood-brain barrier breakdown and the decrease in Na, K-ATPase activity in the cerebral cortex and hippocampus are prevented by dexamethasone in an animal model of maple syrup urine disease Molecular neurobiology"},{"key":"116_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-015-9686-9","author":"CP Mescka","year":"2015","unstructured":"Mescka CP, Guerreiro G, Donida B, Marchetti D, Wayhs CA, Ribas GS, Coitinho AS, Wajner M, Dutra-Filho CS, Vargas CR (2015) Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation. Metab Brain Dis. doi: 10.1007\/s11011-015-9686-9","journal-title":"Metab Brain Dis"},{"key":"116_CR48","first-page":"13","volume-title":"HPLC of small peptides","author":"MH Joseph","year":"1986","unstructured":"Joseph MH, Marsden CA (1986) Amino acids and small peptides. In: CF L (ed) HPLC of small peptides. IRL Press, Oxford, pp. 13\u201327"},{"issue":"1","key":"116_CR49","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ije\/26.1.224","volume":"26","author":"CG Victora","year":"1997","unstructured":"Victora CG, Huttly SR, Fuchs SC, Olinto MT (1997) The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol 26(1):224\u2013227","journal-title":"Int J Epidemiol"},{"issue":"1","key":"116_CR50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10545-006-0223-1","volume":"29","author":"C Roux le","year":"2006","unstructured":"le Roux C, Murphy E, Hallam P, Lilburn M, Orlowska D, Lee P (2006) Neuropsychometric outcome predictors for adults with maple syrup urine disease. J Inherit Metab Dis 29(1):201\u2013202. doi: 10.1007\/s10545-006-0223-1","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"116_CR51","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1172\/JCI67217","volume":"123","author":"ER Muelly","year":"2013","unstructured":"Muelly ER, Moore GJ, Bunce SC, Mack J, Bigler DC, Morton DH, Strauss KA (2013) Biochemical correlates of neuropsychiatric illness in maple syrup urine disease. J Clin Invest 123(4):1809\u20131820. doi: 10.1172\/JCI67217","journal-title":"J Clin Invest"},{"issue":"2","key":"116_CR52","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10545-007-0475-4","volume":"30","author":"E Simon","year":"2007","unstructured":"Simon E, Schwarz M, Wendel U (2007) Social outcome in adults with maple syrup urine disease (MSUD). J Inherit Metab Dis 30(2):264. doi: 10.1007\/s10545-007-0475-4","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"116_CR53","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10545-012-9582-y","volume":"36","author":"D Klee","year":"2013","unstructured":"Klee D, Thimm E, Wittsack HJ, Schubert D, Primke R, Pentang G, Schaper J, Modder U, Antoch A, Wendel U, Cohnen M (2013) Structural white matter changes in adolescents and young adults with maple syrup urine disease. J Inherit Metab Dis 36(6):945\u2013953. doi: 10.1007\/s10545-012-9582-y","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"116_CR54","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10897-007-9114-3","volume":"16","author":"W Packman","year":"2007","unstructured":"Packman W, Henderson SL, Mehta I, Ronen R, Danner D, Chesterman B, Packman S (2007) Psychosocial issues in families affected by maple syrup urine disease. J Genet Couns 16(6):799\u2013809. doi: 10.1007\/s10897-007-9114-3","journal-title":"J Genet Couns"},{"issue":"7","key":"116_CR55","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/mds.23629","volume":"26","author":"M Carecchio","year":"2011","unstructured":"Carecchio M, Schneider SA, Chan H, Lachmann R, Lee PJ, Murphy E, Bhatia KP (2011) Movement disorders in adult surviving patients with maple syrup urine disease. Mov Disord 26(7):1324\u20131328. doi: 10.1002\/mds.23629","journal-title":"Mov Disord"},{"issue":"4","key":"116_CR56","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/13854040903527279","volume":"24","author":"KS Walsh","year":"2010","unstructured":"Walsh KS, Scott MN (2010) Neurocognitive profile in a case of maple syrup urine disease. Clin Neuropsychol 24(4):689\u2013700. doi: 10.1080\/13854040903527279","journal-title":"Clin Neuropsychol"},{"issue":"1","key":"116_CR57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0896-6273(89)90111-6","volume":"3","author":"U Schuch","year":"1989","unstructured":"Schuch U, Lohse MJ, Schachner M (1989) Neural cell adhesion molecules influence second messenger systems. Neuron 3(1):13\u201320","journal-title":"Neuron"},{"key":"116_CR58","first-page":"221","volume":"52","author":"FS Walsh","year":"1997","unstructured":"Walsh FS, Meiri K, Doherty P (1997) Cell signalling and CAM-mediated neurite outgrowth. Soc Gen Physiol Ser 52:221\u2013226","journal-title":"Soc Gen Physiol Ser"},{"issue":"11","key":"116_CR59","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s11064-004-6875-z","volume":"29","author":"PS Walmod","year":"2004","unstructured":"Walmod PS, Kolkova K, Berezin V, Bock E (2004) Zippers make signals: NCAM-mediated molecular interactions and signal transduction. Neurochem Res 29(11):2015\u20132035","journal-title":"Neurochem Res"},{"issue":"2","key":"116_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1471-4159.2005.03208.x","volume":"94","author":"JH Kim","year":"2005","unstructured":"Kim JH, Lee JH, Park JY, Park CH, Yun CO, Lee SH, Lee YS, Son H (2005) Retrovirally transduced NCAM140 facilitates neuronal fate choice of hippocampal progenitor cells. J Neurochem 94(2):417\u2013424. doi: 10.1111\/j.1471-4159.2005.03208.x","journal-title":"J Neurochem"},{"issue":"2","key":"116_CR61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0896-6273(90)90310-C","volume":"5","author":"P Doherty","year":"1990","unstructured":"Doherty P, Cohen J, Walsh FS (1990) Neurite outgrowth in response to transfected N-CAM changes during development and is modulated by polysialic acid. Neuron 5(2):209\u2013219","journal-title":"Neuron"},{"issue":"5","key":"116_CR62","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF01694535","volume":"20","author":"OS Jorgensen","year":"1995","unstructured":"Jorgensen OS (1995) Neural cell adhesion molecule (NCAM) as a quantitative marker in synaptic remodeling. Neurochem Res 20(5):533\u2013547","journal-title":"Neurochem Res"},{"issue":"4","key":"116_CR63","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1134\/S1819712408040028","volume":"2","author":"VP Chekhonin","year":"2008","unstructured":"Chekhonin VP, Shepeleva II, Gurina OI (2008) Disturbances in the expression of neuronal cell adhesion proteins NCAM. Clinical aspects. Neurochem J 2(4):239\u2013251. doi: 10.1134\/S1819712408040028","journal-title":"Neurochem J"},{"issue":"1","key":"116_CR64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1471-4159.2011.07547.x","volume":"120","author":"G Liu","year":"2012","unstructured":"Liu G, Jiang Y, Wang P, Feng R, Jiang N, Chen X, Song H, Chen Z (2012) Cell adhesion molecules contribute to Alzheimer\u2019s disease: multiple pathway analyses of two genome-wide association studies. J Neurochem 120(1):190\u2013198. doi: 10.1111\/j.1471-4159.2011.07547.x","journal-title":"J Neurochem"},{"issue":"2","key":"116_CR65","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.nbd.2003.11.014","volume":"15","author":"L Todaro","year":"2004","unstructured":"Todaro L, Puricelli L, Gioseffi H, Guadalupe Pallotta M, Lastiri J, Bal de Kier Joffe E, Varela M, Sacerdote de Lustig E (2004) Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type. Neurobiol Dis 15(2):387\u2013393. doi: 10.1016\/j.nbd.2003.11.014","journal-title":"Neurobiol Dis"},{"issue":"1","key":"116_CR66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0531-5565(98)00017-5","volume":"34","author":"DT Yew","year":"1999","unstructured":"Yew DT, Li WP, Webb SE, Lai HW, Zhang L (1999) Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: a comparison. Exp Gerontol 34(1):117\u2013133","journal-title":"Exp Gerontol"},{"issue":"2","key":"116_CR67","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JAD-2010-1398","volume":"20","author":"B Aisa","year":"2010","unstructured":"Aisa B, Gil-Bea FJ, Solas M, Garcia-Alloza M, Chen CP, Lai MK, Francis PT, Ramirez MJ (2010) Altered NCAM expression associated with the cholinergic system in Alzheimer\u2019s disease. Journal of Alzheimer\u2019s disease : JAD 20(2):659\u2013668. doi: 10.3233\/JAD-2010-1398","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"issue":"1","key":"116_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2004.11.013","volume":"27","author":"H Strekalova","year":"2006","unstructured":"Strekalova H, Buhmann C, Kleene R, Eggers C, Saffell J, Hemperly J, Weiller C, Muller-Thomsen T, Schachner M (2006) Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes. Neurobiol Aging 27(1):1\u20139. doi: 10.1016\/j.neurobiolaging.2004.11.013","journal-title":"Neurobiol Aging"},{"issue":"23","key":"116_CR69","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1101\/gad.841400","volume":"14","author":"M Bibel","year":"2000","unstructured":"Bibel M, Barde YA (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14(23):2919\u20132937","journal-title":"Genes Dev"},{"key":"116_CR70","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736. doi: 10.1146\/annurev.neuro.24.1.677","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"116_CR71","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11011-015-9768-8","volume":"31","author":"MS Wisniewski","year":"2016","unstructured":"Wisniewski MS, Carvalho-Silva M, Gomes LM, Zapelini HG, Schuck PF, Ferreira GC, Scaini G, Streck EL (2016) Intracerebroventricular administration of alpha-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats. Metab Brain Dis 31(2):377\u2013383. doi: 10.1007\/s11011-015-9768-8","journal-title":"Metab Brain Dis"},{"key":"116_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/neuro.02.001.2010","volume":"3","author":"C Cunha","year":"2010","unstructured":"Cunha C, Brambilla R, Thomas KL (2010) A simple role for BDNF in learning and memory? Front Mol Neurosci 3:1. doi: 10.3389\/neuro.02.001.2010","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"116_CR73","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1073858402238511","volume":"8","author":"WJ Tyler","year":"2002","unstructured":"Tyler WJ, Perrett SP, Pozzo-Miller LD (2002) The role of neurotrophins in neurotransmitter release. Neuroscientist 8(6):524\u2013531","journal-title":"Neuroscientist"},{"issue":"5","key":"116_CR74","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1101\/lm.51202","volume":"9","author":"WJ Tyler","year":"2002","unstructured":"Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD (2002) From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 9(5):224\u2013237. doi: 10.1101\/lm.51202","journal-title":"Learn Mem"},{"issue":"32","key":"116_CR75","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1073\/pnas.0901402106","volume":"106","author":"M Blurton-Jones","year":"2009","unstructured":"Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 106(32):13594\u201313599. doi: 10.1073\/pnas.0901402106","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"116_CR76","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/157015911798376190","volume":"9","author":"SJ Allen","year":"2011","unstructured":"Allen SJ, Watson JJ, Dawbarn D (2011) The neurotrophins and their role in Alzheimer\u2019s disease. Curr Neuropharmacol 9(4):559\u2013573. doi: 10.2174\/157015911798376190","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"116_CR77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","volume":"63","author":"MG Murer","year":"2001","unstructured":"Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer\u2019s disease and Parkinson\u2019s disease. Prog Neurobiol 63(1):71\u2013124","journal-title":"Prog Neurobiol"},{"issue":"4","key":"116_CR78","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ajmg.b.30501","volume":"144B","author":"A Ciammola","year":"2007","unstructured":"Ciammola A, Sassone J, Cannella M, Calza S, Poletti B, Frati L, Squitieri F, Silani V (2007) Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington\u2019s disease patients. American journal of medical genetics part B, neuropsychiatric genetics: the official publication of the International Society of. Psychiatr Genet 144B(4):574\u2013577. doi: 10.1002\/ajmg.b.30501","journal-title":"Psychiatr Genet"},{"issue":"4","key":"116_CR79","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00415-009-5357-2","volume":"257","author":"P Scalzo","year":"2010","unstructured":"Scalzo P, Kummer A, Bretas TL, Cardoso F, Teixeira AL (2010) Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson\u2019s disease. J Neurol 257(4):540\u2013545. doi: 10.1007\/s00415-009-5357-2","journal-title":"J Neurol"},{"issue":"4","key":"116_CR80","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12017-011-8154-x","volume":"13","author":"BS Diniz","year":"2011","unstructured":"Diniz BS, Teixeira AL (2011) Brain-derived neurotrophic factor and Alzheimer\u2019s disease: physiopathology and beyond. Neruomol Med 13(4):217\u2013222. doi: 10.1007\/s12017-011-8154-x","journal-title":"Neruomol Med"},{"issue":"18","key":"116_CR81","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1097\/00001756-199611250-00024","volume":"7","author":"M Narisawa-Saito","year":"1996","unstructured":"Narisawa-Saito M, Wakabayashi K, Tsuji S, Takahashi H, Nawa H (1996) Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer\u2019s disease. Neuroreport 7(18):2925\u20132928","journal-title":"Neuroreport"},{"issue":"5","key":"116_CR82","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0896-6273(91)90273-3","volume":"7","author":"HS Phillips","year":"1991","unstructured":"Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer\u2019s disease. Neuron 7(5):695\u2013702","journal-title":"Neuron"},{"issue":"1\u20132","key":"116_CR83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-328X(97)00125-3","volume":"49","author":"B Connor","year":"1997","unstructured":"Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M (1997) Brain-derived neurotrophic factor is reduced in Alzheimer\u2019s disease. Brain Res Mol Brain Res 49(1\u20132):71\u201381","journal-title":"Brain Res Mol Brain Res"},{"issue":"9","key":"116_CR84","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00702-005-0397-y","volume":"113","author":"C Laske","year":"2006","unstructured":"Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, Richartz E, Bartels M, Buchkremer G, Schott K (2006) Stage-dependent BDNF serum concentrations in Alzheimer\u2019s disease. J Neural Transm 113(9):1217\u20131224. doi: 10.1007\/s00702-005-0397-y","journal-title":"J Neural Transm"},{"key":"116_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pnpbp.2013.12.001","volume":"50","author":"J Platenik","year":"2014","unstructured":"Platenik J, Fisar Z, Buchal R, Jirak R, Kitzlerova E, Zverova M, Raboch J (2014) GSK3beta, CREB, and BDNF in peripheral blood of patients with Alzheimer\u2019s disease and depression. Prog Neuro-Psychopharmacol Biol Psychiatry 50:83\u201393. doi: 10.1016\/j.pnpbp.2013.12.001","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"4","key":"116_CR86","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.nlm.2008.07.014","volume":"90","author":"P Komulainen","year":"2008","unstructured":"Komulainen P, Pedersen M, Hanninen T, Bruunsgaard H, Lakka TA, Kivipelto M, Hassinen M, Rauramaa TH, Pedersen BK, Rauramaa R (2008) BDNF is a novel marker of cognitive function in ageing women: the DR\u2019s EXTRA Study. Neurobiol Learn Mem 90(4):596\u2013603. doi: 10.1016\/j.nlm.2008.07.014","journal-title":"Neurobiol Learn Mem"},{"issue":"9","key":"116_CR87","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/jnr.22041","volume":"87","author":"A Silva","year":"2009","unstructured":"Silva A, Pereira J, Oliveira CR, Relvas JB, Rego AC (2009) BDNF and extracellular matrix regulate differentiation of mice neurosphere-derived cells into a GABAergic neuronal phenotype. J Neurosci Res 87(9):1986\u20131996. doi: 10.1002\/jnr.22041","journal-title":"J Neurosci Res"},{"key":"116_CR88","doi-asserted-by":"publisher","unstructured":"Soltys J, Perrone C, Knight J, Mao-Draayer Y (2011) PDGF-AA and BDNF promote neural stem cell differentiation. Journal of Neurology & Neurophysiology S4. doi: 10.4172\/2155-9562.S4-002","DOI":"10.4172\/2155-9562.S4-002"},{"issue":"5\u20136","key":"116_CR89","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1006\/mcne.1997.0641","volume":"9","author":"A Cellerino","year":"1997","unstructured":"Cellerino A, Carroll P, Thoenen H, Barde YA (1997) Reduced size of retinal ganglion cell axons and hypomyelination in mice lacking brain-derived neurotrophic factor. Mol Cell Neurosci 9(5\u20136):397\u2013408. doi: 10.1006\/mcne.1997.0641","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"116_CR90","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neuroscience.2007.10.050","volume":"151","author":"H JG","year":"2008","unstructured":"JG H, SL F, Wang YX, Li Y, Jiang XY, Wang XF, Qiu MS, PH L, XM X (2008) Platelet-derived growth factor-AA mediates oligodendrocyte lineage differentiation through activation of extracellular signal-regulated kinase signaling pathway. Neuroscience 151(1):138\u2013147. doi: 10.1016\/j.neuroscience.2007.10.050","journal-title":"Neuroscience"},{"issue":"2","key":"116_CR91","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuron.2006.06.012","volume":"51","author":"EL Jackson","year":"2006","unstructured":"Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S, Alvarez-Buylla A (2006) PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 51(2):187\u2013199. doi: 10.1016\/j.neuron.2006.06.012","journal-title":"Neuron"},{"issue":"2","key":"116_CR92","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","volume":"81","author":"N Baumann","year":"2001","unstructured":"Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81(2):871\u2013927","journal-title":"Physiol Rev"},{"issue":"11","key":"116_CR93","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/NEN.0b013e3181587d46","volume":"66","author":"AC Vana","year":"2007","unstructured":"Vana AC, Flint NC, Harwood NE, Le TQ, Fruttiger M, Armstrong RC (2007) Platelet-derived growth factor promotes repair of chronically demyelinated white matter. J Neuropathol Exp Neurol 66(11):975\u2013988. doi: 10.1097\/NEN.0b013e3181587d46","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"116_CR94","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1468-1331.2011.03476.x","volume":"19","author":"MH Harirchian","year":"2012","unstructured":"Harirchian MH, Tekieh AH, Modabbernia A, Aghamollaii V, Tafakhori A, Ghaffarpour M, Sahraian MA, Naji M, Yazdankhah M (2012) Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control study. European journal of neurology: the official journal of the European Federation of Neurological. Societies 19(2):241\u2013247. doi: 10.1111\/j.1468-1331.2011.03476.x","journal-title":"Societies"},{"issue":"1\u20132","key":"116_CR95","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.nbd.2004.12.006","volume":"19","author":"JC Murtie","year":"2005","unstructured":"Murtie JC, Zhou YX, Le TQ, Vana AC, Armstrong RC (2005) PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 19(1\u20132):171\u2013182. doi: 10.1016\/j.nbd.2004.12.006","journal-title":"Neurobiol Dis"},{"issue":"5114","key":"116_CR96","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/bmj.1.5114.90","volume":"1","author":"DY Mackenzie","year":"1959","unstructured":"Mackenzie DY, Woolf LI (1959) Maple syrup urine disease; an inborn error of the metabolism of valine, leucine, and isoleucine associated with gross mental deficiency. Br Med J 1(5114):90\u201391","journal-title":"Br Med J"},{"issue":"3","key":"116_CR97","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bbrc.2011.09.081","volume":"414","author":"M Agostini","year":"2011","unstructured":"Agostini M, Tucci P, Melino G (2011) Cell death pathology: perspective for human diseases. Biochem Biophys Res Commun 414(3):451\u2013455. doi: 10.1016\/j.bbrc.2011.09.081","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"116_CR98","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/exnr.1997.6603","volume":"147","author":"M Hetman","year":"1997","unstructured":"Hetman M, Danysz W, Kaczmarek L (1997) Increased expression of cathepsin D in retrosplenial cortex of MK-801-treated rats. Exp Neurol 147(2):229\u2013237. doi: 10.1006\/exnr.1997.6603","journal-title":"Exp Neurol"},{"issue":"3","key":"116_CR99","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0306-4522(98)00599-5","volume":"91","author":"D Moechars","year":"1999","unstructured":"Moechars D, Lorent K, Van Leuven F (1999) Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis. Neuroscience 91(3):819\u2013830","journal-title":"Neuroscience"},{"issue":"3","key":"116_CR100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0306-4522(01)00517-6","volume":"109","author":"DC German","year":"2002","unstructured":"German DC, Liang CL, Song T, Yazdani U, Xie C, Dietschy JM (2002) Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience 109(3):437\u2013450","journal-title":"Neuroscience"},{"issue":"4","key":"116_CR101","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/j.1471-4159.2008.05278.x","volume":"105","author":"A Gowran","year":"2008","unstructured":"Gowran A, Campbell VA (2008) A role for p53 in the regulation of lysosomal permeability by delta 9-tetrahydrocannabinol in rat cortical neurones: implications for neurodegeneration. J Neurochem 105(4):1513\u20131524. doi: 10.1111\/j.1471-4159.2008.05278.x","journal-title":"J Neurochem"},{"issue":"5","key":"116_CR102","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.neurobiolaging.2008.06.011","volume":"31","author":"O Wirths","year":"2010","unstructured":"Wirths O, Breyhan H, Marcello A, Cotel MC, Bruck W, Bayer TA (2010) Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP\/PS1KI mouse model of Alzheimer\u2019s disease. Neurobiol Aging 31(5):747\u2013757. doi: 10.1016\/j.neurobiolaging.2008.06.011","journal-title":"Neurobiol Aging"},{"key":"116_CR103","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1750-1326-6-52","volume":"6","author":"SV Yelamanchili","year":"2011","unstructured":"Yelamanchili SV, Chaudhuri AD, Flynn CT, Fox HS (2011) Upregulation of cathepsin D in the caudate nucleus of primates with experimental parkinsonism. Mol Neurodegener 6:52. doi: 10.1186\/1750-1326-6-52","journal-title":"Mol Neurodegener"},{"issue":"1","key":"116_CR104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1432-1033.1975.tb02342.x","volume":"58","author":"RT Dean","year":"1975","unstructured":"Dean RT (1975) Lysosomal enzymes as agents of turnover of soluble cytoplasmic proteins. European journal of biochemistry \/ FEBS 58(1):9\u201314","journal-title":"European journal of biochemistry \/ FEBS"},{"issue":"15","key":"116_CR105","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1002\/j.1460-2075.1996.tb00760.x","volume":"15","author":"LP Deiss","year":"1996","unstructured":"Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A (1996) Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas\/APO-1 and TNF-alpha. EMBO J 15(15):3861\u20133870","journal-title":"EMBO J"},{"issue":"1","key":"116_CR106","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ydbio.2006.08.008","volume":"301","author":"V Zuzarte-Luis","year":"2007","unstructured":"Zuzarte-Luis V, Montero JA, Kawakami Y, Izpisua-Belmonte JC, Hurle JM (2007) Lysosomal cathepsins in embryonic programmed cell death. Dev Biol 301(1):205\u2013217. doi: 10.1016\/j.ydbio.2006.08.008","journal-title":"Dev Biol"},{"issue":"3","key":"116_CR107","first-page":"159","volume":"45","author":"A Minarowska","year":"2007","unstructured":"Minarowska A, Minarowski L, Karwowska A, Gacko M (2007) Regulatory role of cathepsin D in apoptosis. Folia histochemica et cytobiologica \/ Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 45(3):159\u2013163","journal-title":"Folia histochemica et cytobiologica \/ Polish Academy of Sciences, Polish Histochemical and Cytochemical Society"},{"issue":"2","key":"116_CR108","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.canlet.2005.06.007","volume":"237","author":"E Liaudet-Coopman","year":"2006","unstructured":"Liaudet-Coopman E, Beaujouin M, Derocq D, Garcia M, Glondu-Lassis M, Laurent-Matha V, Prebois C, Rochefort H, Vignon F (2006) Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett 237(2):167\u2013179. doi: 10.1016\/j.canlet.2005.06.007","journal-title":"Cancer Lett"},{"issue":"5","key":"116_CR109","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.cdd.4401382","volume":"11","author":"M Heinrich","year":"2004","unstructured":"Heinrich M, Neumeyer J, Jakob M, Hallas C, Tchikov V, Winoto-Morbach S, Wickel M, Schneider-Brachert W, Trauzold A, Hethke A, Schutze S (2004) Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ 11(5):550\u2013563. doi: 10.1038\/sj.cdd.4401382","journal-title":"Cell Death Differ"},{"issue":"5","key":"116_CR110","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1158\/1535-7163.MCT-04-0301","volume":"4","author":"L Emert-Sedlak","year":"2005","unstructured":"Emert-Sedlak L, Shangary S, Rabinovitz A, Miranda MB, Delach SM, Johnson DE (2005) Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death. Mol Cancer Ther 4(5):733\u2013742. doi: 10.1158\/1535-7163.MCT-04-0301","journal-title":"Mol Cancer Ther"},{"issue":"17","key":"116_CR111","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/sj.onc.1201755","volume":"16","author":"W GS","year":"1998","unstructured":"GS W, Saftig P, Peters C, El-Deiry WS (1998) Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 16(17):2177\u20132183. doi: 10.1038\/sj.onc.1201755","journal-title":"Oncogene"},{"issue":"11\u201312","key":"116_CR112","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0891-5849(99)00146-X","volume":"27","author":"K Roberg","year":"1999","unstructured":"Roberg K, Johansson U, Ollinger K (1999) Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic Biol Med 27(11\u201312):1228\u20131237","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"116_CR113","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1096\/fj.00-0708fje","volume":"15","author":"K Kagedal","year":"2001","unstructured":"Kagedal K, Johansson U, Ollinger K (2001) The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 15(9):1592\u20131594","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"3","key":"116_CR114","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/jir.2006.0105","volume":"27","author":"M Fusek","year":"2007","unstructured":"Fusek M, Vetvickova J, Vetvicka V (2007) Secretion of cytokines in breast cancer cells: the molecular mechanism of procathepsin D proliferative effects. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 27(3):191\u2013199. doi: 10.1089\/jir.2006.0105","journal-title":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research"},{"issue":"5","key":"116_CR115","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejcb.2008.01.005","volume":"87","author":"S Erdmann","year":"2008","unstructured":"Erdmann S, Ricken A, Hummitzsch K, Merkwitz C, Schliebe N, Gaunitz F, Strotmann R, Spanel-Borowski K (2008) Inflammatory cytokines increase extracellular procathepsin D in permanent and primary endothelial cell cultures. Eur J Cell Biol 87(5):311\u2013323. doi: 10.1016\/j.ejcb.2008.01.005","journal-title":"Eur J Cell Biol"},{"issue":"6","key":"116_CR116","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1111\/j.1471-4159.2007.04995.x","volume":"103","author":"S Kim","year":"2007","unstructured":"Kim S, Ock J, Kim AK, Lee HW, Cho JY, Kim DR, Park JY, Suk K (2007) Neurotoxicity of microglial cathepsin D revealed by secretome analysis. J Neurochem 103(6):2640\u20132650. doi: 10.1111\/j.1471-4159.2007.04995.x","journal-title":"J Neurochem"}],"updated-by":[{"DOI":"10.1007\/s12035-016-0263-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0116-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0116-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0116-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T21:38:18Z","timestamp":1568410698000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0116-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":116,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["116"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0116-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12035-016-0263-y","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,22]]}}}